摘要
Background Integrin-linked kinase （ILK） dysregulation is involved in the progression of diabetic nephropathy （DN）. The aim of this study was to investigate the effects of angiotensin II receptor blocker （ARB）, irbesartan, on ILK expression and podocyte injury in DN.
Background Integrin-linked kinase （ILK） dysregulation is involved in the progression of diabetic nephropathy （DN）. The aim of this study was to investigate the effects of angiotensin II receptor blocker （ARB）, irbesartan, on ILK expression and podocyte injury in DN.
基金
This study was supported by a grant from the National Natural Science Foundation of China （No. 30870953） to Prof. LIU Bi-cheng as PI.
